ArticleAnnals of hematology2025

Challenges in managing iTTP: insights into ADAMTS13 inhibitor boosting during caplacizumab therapy.

Haruyuki Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.